The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
(By Ed Silverman for STAT) Two documents dating back to 2015 shed further light on the role the federal government
Read More(By Ed Silverman for STAT) Two documents dating back to 2015 shed further light on the role the federal government
Read More(By Morgan Haefner for Becker’s Hospital Review) Cigna will pay out-of-network providers market-based rates for treatment provided to its members with
Read MoreUnitedHealth Group announced its fully insured members will receive a credit of 5 to 20 percent on their June premium
Read More(By Katie Adams for Becker’s Hospital Review) The cost of shipping pharmaceuticals to the U.S has increased by an average
Read MoreHumana, the nation’s second-largest provider of Medicare Advantage plans, announced that it is waiving copayments, deductibles and other out-of-pocket costs
Read MoreGilead has not yet set a price for the first coronavirus treatment to have shown clinical benefits; however, the Institute
Read MoreExpress Scripts and CVS Caremark, the two largest pharmacy benefit managers, increased the numbers of drugs on their 2020 exclusion
Read More(By Maia Anderson for Becker’s Hospital Review) The costs of dozens of cancer drugs were about 2.3 times higher in the
Read More(By Ayla Ellison for Becker’s Hospita Review) CMS has issued another round of sweeping rule changes and regulatory waivers, giving physicians,
Read More( By Maia Anderson for Becker’s Hospital Review) Walgreens cut the costs of hundreds of its prescription drugs in response
Read More